Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.

MLA

Rajarajan A Thandavarayan, et al. “Schisandrin B Prevents Doxorubicin Induced Cardiac Dysfunction by Modulation of DNA Damage, Oxidative Stress and Inflammation through Inhibition of MAPK/P53 Signaling.” PLoS ONE, vol. 10, no. 3, Jan. 2015, p. e0119214. EBSCOhost, https://doi.org/10.1371/journal.pone.0119214.

APA

Rajarajan A Thandavarayan, Vijayasree V Giridharan, Somasundaram Arumugam, Kenji Suzuki, Kam Ming Ko, Prasanna Krishnamurthy, Kenichi Watanabe, & Tetsuya Konishi. (2015). Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS ONE, 10(3), e0119214. https://doi.org/10.1371/journal.pone.0119214

Chicago

Rajarajan A Thandavarayan, Vijayasree V Giridharan, Somasundaram Arumugam, Kenji Suzuki, Kam Ming Ko, Prasanna Krishnamurthy, Kenichi Watanabe, and Tetsuya Konishi. 2015. “Schisandrin B Prevents Doxorubicin Induced Cardiac Dysfunction by Modulation of DNA Damage, Oxidative Stress and Inflammation through Inhibition of MAPK/P53 Signaling.” PLoS ONE 10 (3): e0119214. doi:10.1371/journal.pone.0119214.